Research into developing new antimicrobial resistance treatment in Nigeria and other low/middle-income countries has fuelled a ...
Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their dependability has waned as antibiotic resistant bacteria continues to ...
A comprehensive seven-year study across 20 Chinese provinces has revealed a concerning rise in antimicrobial resistance (AMR) ...
The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome are collaborating on a $50 million effort to boost ...
Antibiotics are powerful, fast-acting medications designed to eradicate bacterial infections. However, in recent years, their ...
People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...
Research into developing new antimicrobial resistance treatments in Nigeria and other low/middle-income countries has secured ...
MiscellaneousBIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE 11.02.2025 / 07:00 CET/CESTBasel, Switzerland. February 11, 2025, 7am CET BV500 reaches ...
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI) ...
The FDA announced the approval of a new treatment for pneumonia caused by certain difficult-to-treat bacteria, offering hope ...
Sir Jim Ratcliffe has been presented with the Sheldon Medal by the University of Oxford in recognition of the company’s generous support.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback